Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Molecular Cancer
|
October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Molecular Cancer
|
March 26, 2021
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Fan Li, Yan Xu, Bovey Liu, et al.
Blood
|
May 27, 2021
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
Vicki Plaks, John M Rossi, Justin Chou, et al.
Cancer Research
|
December 2, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
Ziheng Chen, I-Lin Ho, Jintan Liu, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Cancers
|
November 13, 2021
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
Robert A Szczepaniak Sloane, Michael G White, Russell G Witt, et al.
Science Translational Medicine
|
May 10, 2019
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang, Yixin Yao, Shaojun Zhang, et al.
Nature Communications
|
August 24, 2024
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics
Jiahui Jiang, Yunhe Liu, Jiangjiang Qin, et al.
Nature Communications
|
September 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Guangchun Han, Guoliang Yang, Dapeng Hao, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Molecular Cancer
|
October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Molecular Cancer
|
March 26, 2021
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Fan Li, Yan Xu, Bovey Liu, et al.
Blood
|
May 27, 2021
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
Vicki Plaks, John M Rossi, Justin Chou, et al.
Cancer Research
|
December 2, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
Ziheng Chen, I-Lin Ho, Jintan Liu, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Cancers
|
November 13, 2021
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
Robert A Szczepaniak Sloane, Michael G White, Russell G Witt, et al.
Science Translational Medicine
|
May 10, 2019
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang, Yixin Yao, Shaojun Zhang, et al.
Nature Communications
|
August 24, 2024
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics
Jiahui Jiang, Yunhe Liu, Jiangjiang Qin, et al.
Nature Communications
|
September 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Guangchun Han, Guoliang Yang, Dapeng Hao, et al.
Page
of 6